Benson Mukonzo B. Small R. Bowers

103 MONDAY SCIENTIFIC SESSIONS Final Program H-888 High Incidence of Renal Stones in HIV-Infected Patients on Ritonavir-Boosted Atazanavir Than in Those on Other Protease Inhibitors-Containing Antiretroviral Therapy

Y. Hamada

1 , T. Nishijima 1 , K. Watanabe 1 , H. Komatsu 2 , K. Tsukada 1 , H. Gatanaga 1 , Y. Kikuchi 1 , S. Oka 1 ; 1 AIDS clinical Ctr., Natl. Ctr. for Global Hlth. and Med., Tokyo, Japan, 2 Saku Central Hosp., Nagano, Japan. H-889 High ATZ and DRV Urine Concentrations and Cristalluria in Asymptomatic Patients Receiving ATV and DRV-Based Regimens

V. de Lastours

1 , E. Silva 1 , M. Daudon 2 , R. Porcher 1 , H. Sauvageon 1 , J. Molina 1 ; 1 Saint-Louis Hosp., Paris, France, 2 Tenon Hosp., Paris, France. H-890 Single Nucleotide Polymorphisms in ABCC2 Predict Teno- fovir-Induced Kidney Tubular Dysfunction in Japanese Patients with HIV Infection: A Pharmacogenetic Study

T. Nishijima

1 , H. Komatsu 2 , K. Higasa 3 , M. Takano, RN 1 , T. Hayashida 1 , K. Tsuchiya 1 , R. Yamada 3 , S. Oka 1 , H. Gatanaga 1 ; 1 Natl. Ctr. for Global Hlth. and Med., Tokyo, Japan, 2 Saku Central Hosp., Saku, Japan, 3 Kyoto Univ., Kyoto, Japan. H-891 Renal Safety Profile of Cobicistat-Boosted Elvitegravir or Atazanavir plus EmtricitabineTenofovir DF in HIV Patients

P. Benson

1 , C. Mayer, MO 2 , J. Morales Ramirez 3 , M. Rhee 4 ; 1 Be Well Med. Ctr., Berkley, MI, 2 St. Joseph’s Comprehensive Res. Inst., Tampa, FL, 3 Clin. Res. Puerto Rico, San Juan, Puerto Rico, 4 Gilead Sci., Foster City, CA. H-892 Cobicistat Does Not Affect the In Vitro Renal Transport or Cytotoxicity of Tenofovir K. Stray, R. Bam, G. Birkus, J. Hao , I. Lepist , S. Yant , A. Ray, T. Cihlar; Gilead Sci., Foster City, CA. H-893 Pharmacogenetic Aspects of HIVAIDS and Tuberculosis Treatments: Emphasis on Ugandan Population

J. Mukonzo

1,1 , J. Ogwal-Okeng 1 , P. Waako 2 , L. L. Gustafsson 3 , E. Aklillu 3 ; 1 Makerere Univ., Coll. of Hlth. Sci., Kampala, Uganda, 2 Makerere Univ., College of Hlth. Sci., Uganda, 3 Karolinska Inst., Stockholm, Sweden. H-894 Impact of Seven Nucleotide Polymorphisms and Haplotypes of CYP2B6 on Plasma Efavirenz Level in HIVTuberculosis Co-Infected Thai Patients Receiving Rifampicin W. Manosuthi 1 , C. Sukasem 2 , A. Lueangniyomkul 1 , W. Mankatitham 1 , S. Thongyen 1 , S. Nilkamhang 1 , S. Manosuthi 1 , S. Sungkanuparph 2 ; 1 Bamrasnaradura Infectious Dis. Inst., Ministry of Publ. Health, Nonthaburi, Thailand, 2 Faculty of Med. Ramathibodi Hosp., Mahidol Univ., Bangkok, Thailand. H-895 Prevalence of HLA-B5701 Allele in HIV-Infected Subjects in North America and Reductions in Risk for Development of Abacavir Associated Hypersensitivity Reaction ABC HSR

C. B. Small

1 , D. Wohl 2 , D. A. Margolis 3 , L. L. Ross 3 , B. Wine 3 , H. Zhao 3 , M. S. Shaefer 4 ; 1 New York Med. Coll., Valhalla, NY, 2 AIDS Clin Trials Unit, UNC CH, Chapel Hill, NC, 3 GlaxoSmithKline, Research Triangle Park, NC, 4 ViiV Healthcare, Research Triangle Park, NC. ------------------------------------------------------------------------ 104 K Poster Session Blood Stream Infections Monday, 11:15 a.m.–1:15 p.m. . . . . . . . . . . . . . . . . . . . Halls A-C Presentations: K-896 Outcome of Appropriate Empiric Combination versus Monotherapy for Pseudomonas aeruginosa Bacteremia

D. R. Bowers

1,2 , Y. X. Liew 3 , D. C. Lye 4,5 , A. L. Kwa 3 , L. Y. Hsu 5 , V. H. Tam 1,2,5 ; 1 St Luke’s Episcopal Hosp., Houston, TX, 2 Univ. of Houston, Houston, TX, 3 Singapore Gen Hosp., Singapore, Singapore, 4 Tan Tock Seng Hosp, Singapore, Singapore, 5 Natl. Univ. of Singapore, Singapore, Singapore. K-897 Clinical and Microbiological Characteristics of Helicobacter cinaedi Bacteremia in Japan H. Araoka, M. Baba, H. Inagawa, M. Kimura, A. Yoneyama; Toranomon Hosp., Tokyo, Japan.